@misc{indiciae3581e04588b8,
  title = {Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma.},
  author = {Visaga, S. A. and Kalonia, H. and Verma, V. and Sinha, S. and Singh, S. K. and Upadhyay, S. and Sahdev, S. and Pansari, A. and Kumar, R. and Bandgar, M. and Karanjule, N. and Shirumalla, R. K. and Morishita, K. and Tandon, R.},
  year = {2021},
  doi = {10.1101/2021.09.16.460577},
  url = {https://www.biorxiv.org/content/10.1101/2021.09.16.460577v1},
  note = {Source identifier: 10.1101/2021.09.16.460577}
}